After a stroke, the best time to work on regaining hand and arm use is 60 to 90 days later, according to a new clinical trial. Starting intensive rehab at less than 30 days can be helpful,...

Potentially dangerous symptoms of type 1 diabetes in children are not always immediately recognized by primary care providers, new research suggests. In type 1 diabetes, the pancreas fails to make enough insulin, the hormone that helps regulate...

After more than a year at home, children are heading back to classrooms across the country. But they’re also toting heavy bags on their backs again. A backpack that fits properly — and is not overloaded with...

New research offers good news for women with an aggressive HER2-positive breast cancer. A targeted therapy, trastuzumab deruxtecan (T-DXd), sold as Enhertu, triples the length of time that the cancer remains in check when compared with the...

Millions of U.S. sleep apnea patients are scrambling to find ways to protect their nightly slumber, following a voluntary recall from one of the nation’s leading manufacturers of CPAP breathing machines. Philips Respironics agreed to a voluntary...

Starting in November, the United States plans to lift travel restrictions on people coming from overseas who are fully vaccinated against COVID-19. This move by the Biden administration will open the United States to relatives separated from...

Pregnant women infected with certain strains of human papillomavirus (HPV) may have a heightened risk of preterm birth, a new study suggests. HPV is a sexually transmitted disease that can cause genital warts. Most of the time,...

MONDAY, Sept. 20, 2021 (American Heart Association News) — Physically removing a blood clot in the brain is a safe and effective treatment for pregnant women having a stroke, a new study suggests. Stroke during pregnancy remains...

Here are some of HealthDay’s top stories for Monday, Sept. 20: Lower dose of Pfizer vaccine works in kids as young as 5: The pharmaceutical giant announced Monday that a dose that is one-third the strength of...

A smaller dose of Pfizer’s coronavirus vaccine safely triggers a strong immune response in children as young as 5, the company announced Monday morning. “Over the past nine months, hundreds of millions of people ages 12 and...